Metraipolis › archive › dc_7e3cbc1edcd7
Use of Testosterone-Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series — Europe PMC PMID:42256464
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42256464
- DOI
- 10.1155/crps/6191292
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T02:02:41.836Z
- SHA-256 of the archived text
641ae066eb0b772293b440703e91e7ee12a12944c6dacf34aeff76fb94f9d1cd- Stable URL of this page
https://metraipolis.com/documento/dc_7e3cbc1edcd7
How to cite
Use of Testosterone-Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series — Europe PMC PMID:42256464 — Europe PMC (en), https://europepmc.org/article/MED/42256464 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e3cbc1edcd7 (Metraipolis archive dc_7e3cbc1edcd7, sha256 641ae066eb0b772293b440703e91e7ee12a12944c6dacf34aeff76fb94f9d1cd)
BibTeX
@misc{dc7e3cbc1edcd7,
title = {Use of Testosterone-Lowering Medication in Patients With Intellectual Disabilities and Problematic Sexual Behaviour: A Case Series — Europe PMC PMID:42256464},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42256464},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e3cbc1edcd7; sha256 641ae066eb0b772293b440703e91e7ee12a12944c6dacf34aeff76fb94f9d1cd},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42256464. Agents can read the archived copy with the MCP tool read_document.